Growth visibility high for ACs; FY21-23 EPS up 9-10%; TP up to Rs 1274; ‘Buy’ retained
Voltas Rating: Buy; results were well ahead of estimates
By The Financial Express8 days ago
Continue read on financialexpress.com
Sponsored
Most Read News
Novimmune and Sobi Get FDA Approval for First Ever Primary HLH Therapy
Geron's Imetelstat Reaffirmed as a Priority for Johnson & Johnson
Sanofi Gets FDA Approval for Highest Capacity Long-Acting Insulin Pen
Morad Fareed, Dr. Jie Zhao, Alison Tracy, Dr. Ana Langer, and Jennie Joseph...
Ahold's Quarterly Profit Boosted By US Stores, Online Sales
Geron's Imetelstat Reaffirmed as a Priority for Johnson & Johnson
Sanofi Gets FDA Approval for Highest Capacity Long-Acting Insulin Pen
Morad Fareed, Dr. Jie Zhao, Alison Tracy, Dr. Ana Langer, and Jennie Joseph...
Ahold's Quarterly Profit Boosted By US Stores, Online Sales